LIMG
LIMITATION OF GOODS RECEIVED FROM IB
08/29/2025
Back to search
Official data from USPTO
MEPSGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
MEPSGEN
ST13
US500000079348988Class
5, 9, 10, 35, 42
Filing
79348988
Registration
7490516
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
04/03/2026
Classification
Registered
Trademark type
Word
Nice classes
5, 9, 10, 35, 42
Filing date
04/28/2022
Registration date
09/03/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/03/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
KR
Examiner
CORNWELL, ANDREA B
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
MEPSGEN Co., LTD.
Representatives
LEIGH ANN LINDQUIST SUGHRUE MION PLLC
Technical classification
Nice Classes
Class 5Class 9Class 10Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical products for treating respiratory diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; stimulants for the central nervous system; pharmaceutical preparations for tumor treatment; tissue- regenerative pharmaceutical preparations; pharmaceutical preparations for use in tissue transplantation; clinical diagnostic reagents; clinical medical reagents; pharmaceuticals for the treatment of Parkinson's diseaseAlzheimer's diseaseNeurocognitive disorderNeurodegenerative diseaseCancerBrain disease; pharmaceutical compositions for treating Parkinson's diseaseAlzheimer's diseaseNeurocognitive disorderNeurodegenerative diseasecancerbrain disease; pharmaceutical drugs for treating Parkinson's diseaseAlzheimer's diseaseNeurocognitive disorderNeurodegenerative diseasecancerbrain disease; cells for medical purposes; pharmaceutical preparations for the treatment of inflammatory diseases; pharmaceutical preparations for the prevention of inflammatory disorders; biopharmaceuticals for the treatment of cancer; pharmaceutical preparations for the treatment of cardiovascular disease; cardiovascular pharmaceuticals; pharmaceutical preparations for the prevention of disorders of the nervous system; cardiovascular treatment preparations; cardiovascular pharmaceutical preparations; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for immunity adjustment; pharmaceutical agents affecting metabolism; pharmaceutical preparations for the treatment of diseases of the endocrine system; pharmaceutical preparations for the prevention of diseases of the endocrine system; pharmaceutical products for the treatment of infectious diseases
Class 9
Biochips for research or scientific purposes; biochip analyzing apparatuselectronic biochip inspection device for testing functionality of biochips; apparatus for inspecting biochips for laboratory useelectronic biochip inspection device for testing functionality of biochips; apparatus for analyzing biochips for laboratory useelectronic biochip analysis device for analyzing functionality of biochips; apparatus for manufacturing biochips for laboratory useelectronic installations for the remote control of industrial biochip manufacturing operations; laboratory apparatus for analyzing biological pharmaceuticalslaboratory analysis device for analyzing efficacypotencytoxicity evaluations of biological pharmaceuticals; microchips
Class 10
Medical diagnostic apparatus for the detection of cardiovascular diseases; medical apparatus and instruments for use in medical examination and treatment of cardiovascular diseases; cell culture instruments for medical usecell culture chambers
Class 35
Wholesale store services featuring cell growth media for growing cells for use in scientific research; retail store services featuring cell growth media for growing cells for use in scientific research; wholesale store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; retail store services featuring biological preparation for use in cell cultures other than for medical or veterinary use; wholesale store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring cardiovascular pharmaceuticals; retail store services featuring cardiovascular pharmaceuticals; wholesale store services featuring chemico-pharmaceutical preparations; retail store services featuring chemico-pharmaceutical preparations; wholesale store services featuring medical instruments; retail store services featuring medical instruments; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring biological preparations for medical or veterinary purposes; retail store services featuring biological preparations for medical or veterinary purposes; wholesale store services featuring biotechnological preparations for medical purposes; retail store services featuring biotechnological preparations for medical purposes; wholesale store services featuring biological reagents for medical purposes; retail store services featuring biological reagents for medical purposes; wholesale store services featuring biological tissue cultures for medical purposes; retail store services featuring biological tissue cultures for medical purposes; wholesale store services featuring biological preparations for medical purposes; retail store services featuring biological preparations for medical purposes; wholesale store services featuring living cells for medical purposes; retail store services featuring living cells for medical purposes; wholesale store services featuring cells for medical purposes; retail store services featuring cells for medical purposes; wholesale store services featuring cell culture instruments for medical use; retail store services featuring cell culture instruments for medical use; wholesale store services featuring cardiovascular agents for medical purposes; retail store services featuring cardiovascular agents for medical purposes; wholesale store services featuring drugs for medical purposes; retail store services featuring drugs for medical purposes; wholesale store services featuring stem cells for medical purposes; retail store services featuring stem cells for medical purposes; wholesale store services featuring chemical preparations for medical purposes; retail store services featuring chemical preparations for medical purposes
Class 42
Crude medicines research; drug discovery services; development of cell therapy products; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals; pharmaceutical drug development; research on the subject of pharmaceuticals; scientific research in the field of pharmacy; medical studies in the nature of medical and scientific researchconducting clinical trials for otherstranslational research and medical and scientific research; scientific research services for medical purposes in the field of cancerous diseasesCNS diseasesbrain diseases; drug deliverymedicinal effectBiological or biotechnological research for medical products; development of biotechnologymedical drug and biochip products; biotechnology research; laboratory research in the field of biology; development of biologicsvaccine and therapeutic drug products; research in the field of chemistry; technological studies in the nature of biotechnology and microfluidics research; research and development of medical equipment; development of medical devices; conducting clinical trials in the field of cardiovascular disease; conducting early efficacypotencytoxicity evaluations in the field of new pharmaceuticals; conducting early pharmaceutical product evaluations in the field of new pharmaceuticals; testing of pharmaceuticals; laboratory research services relating to pharmaceuticals; providing information on the testinginspectionresearch of medical products; consultancy in the field of testinginspectionresearch of medical productspharmaceuticalspharmaceutical preparations and pharmaceutical compositions; pharmaceutical product evaluation; design of devices for biological medicine analysis; development of devices for biological chemicals analysis; development of devices for biochemical chemicals; microchip design services
Publications
History of USPTO decisions and trademark events.
45 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/08/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
02/16/2025
FIMP
FINAL DISPOSITION PROCESSED
02/16/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/03/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/03/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
09/03/2024
GPNX
NOTIFICATION PROCESSED BY IB
07/01/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/18/2024
PUBO
PUBLISHED FOR OPPOSITION
06/18/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/11/2024
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/11/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/29/2024
EXPT
EXPARTE APPEAL TERMINATED
05/16/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/16/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
05/16/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/16/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
05/16/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/16/2024
EXPI
EX PARTE APPEAL-INSTITUTED
05/14/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
05/14/2024
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
05/14/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/29/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/29/2024
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
04/29/2024
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/03/2024
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/14/2024
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/14/2024
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/14/2023
GNFR
FINAL REFUSAL E-MAILED
11/14/2023
CNFR
FINAL REFUSAL WRITTEN
11/14/2023
DMCC
DATA MODIFICATION COMPLETED
11/01/2023
ALIE
ASSIGNED TO LIE
11/01/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/17/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/17/2023
RFNT
REFUSAL PROCESSED BY IB
05/10/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/17/2023
RFRR
REFUSAL PROCESSED BY MPU
04/17/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/25/2023
CNRT
NON-FINAL ACTION WRITTEN
02/24/2023
DOCK
ASSIGNED TO EXAMINER
02/16/2023
MAFR
APPLICATION FILING RECEIPT MAILED
09/13/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/09/2022
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/08/2022
Continuous trademark protection
Get notified about every new filing that threatens MEPSGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.